Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

When it comes to health foods, cheese is a champ. For starters, dietary gurus have decreed that unlike the mostly saturated ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...

Sleep apnea causes people to ... found that those who used it saw reduction in apnea events “This is a major step forward for patients with obstructive sleep apnea,” Dr. Sally Seymour ...

Obstructive Sleep Apnea is more common in those who ... which makes it seem that the improvement in AHI and sleep apnea symptoms in those with OSA is related to weight reduction due to Zepbound.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...